Hims & Hers announced on Saturday that it will cease the sale of its compounded version of Novo Nordisk’s obesity medication. This decision follows a request...
A biotechnology firm based in San Diego, Neomorph, has initiated its first clinical trial aimed at treating a specific type of kidney cancer using a novel...
New dietary guidelines released this year emphasize a reduction in the consumption of ultra-processed foods while promoting healthy protein sources and easing restrictions on saturated fats....
A prominent surgeon has issued a warning about the dangers of vitamin D deficiency, particularly for individuals who spend long periods sitting. According to the surgeon,...
Overcoming the challenge of chemotherapy-resistant cancer cells has long posed difficulties for oncology clinicians and researchers. A recent study indicates that by blocking a crucial protein...
A recent meta-analysis published in The Lancet challenges the prevailing notions about the side effects of statins, a widely prescribed class of cholesterol-lowering medications. The study...
A recent clinical trial has shown that the oral medication enlicitide significantly reduces low-density lipoprotein cholesterol (LDL-C) levels in patients at risk for atherosclerotic cardiovascular disease...
The increasing prevalence of fentanyl in the illicit drug market is prompting significant changes in how health care providers treat opioid use disorder (OUD). Traditionally, medications...
Nektar Therapeutics is navigating a challenging landscape as it prepares for crucial results from its Phase 2 study on a treatment for moderate-to-severe eczema, also known...
As healthcare costs rise and patients expect more from their insurance coverage, the pressure on healthcare payers to deliver higher-quality care efficiently has intensified. To meet...
